Page last updated: 2024-09-03

kallidin, des-arg(10)- and Breast Cancer

kallidin, des-arg(10)- has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L1
Bhoola, KD; Borquez, C; Ehrenfeld, P; Figueroa, CD; Lizama, A; Manso, L; Matus, CE; Naran, A; Pavicic, MF; Poblete, MT; Sarmiento, J1

Other Studies

2 other study(ies) available for kallidin, des-arg(10)- and Breast Cancer

ArticleYear
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship

2013
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
    Anticancer research, 2014, Volume: 34, Issue:12

    Topics: Bradykinin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Humans; Kallidin; Kallikreins; Kininogens; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Neoplasm Invasiveness; Receptor, Bradykinin B1; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Tissue Kallikreins; Up-Regulation

2014